Notably, TCF1‒CXCR6+ effector cells have also been identified across various CD4+ T-cell-mediated immune responses, highlighting the need for further studies to define their molecular regulation and precise role in driving tissue damage in autoimmunity and allograft rejection [11, 93, 94]. This evidence concerns the gene CD4 and Autoimmunity.